Andersons pediatric cardiology 1675

193 Yang CF, Yang CC, Liao HC, et al Very early treatment for Infantile-onset pompe disease contributes to better outcomes J Pediatr 2016;169:174–180 e171 194 Maron BJ, Gottdiener JS, Bonow RO, Epstein SE Hypertrophic cardiomyopathy with unusual locations of left ventricular hypertrophy undetectable by M-mode echocardiography Identification by wide-angle two-dimensional echocardiography Circulation 1981;63(2):409– 418 195 Maron BJ, Bonow RO, Seshagiri TN, Roberts WC, Epstein SE Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy) Am J Cardiol 1982;49(8):1838–1848 196 Yamaguchi H, Ishimura T, Nishiyama S, et al Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients Am J Cardiol 1979;44(3):401–412 197 Shapiro LM, McKenna WJ Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study J Am Coll Cardiol 1983;2(3):437–444 198 Maron MS, Hauser TH, Dubrow E, et al Right ventricular involvement in hypertrophic cardiomyopathy Am J Cardiol 2007;100(8):1293–1298 199 Kwon DH, Setser RM, Thamilarasan M, et al Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy Heart 2008;94(10):1295–1301 200 Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae J Thorac Cardiovasc Surg 2004;127(2):481–489 201 Harrigan CJ, Appelbaum E, Maron BJ, et al Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy Am J Cardiol 2008;101(5):668–673 202 Klues HG, Roberts WC, Maron BJ Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy Significance in producing left ventricular outflow obstruction Circulation 1991;84(3):1188–1197 203 Schantz D, Benson L, Windram J, et al Abnormal mitral valve dimensions in pediatric patients with hypertrophic cardiomyopathy Pediatr Cardiol 2016;37(4):784–788 204 Sorajja P, Ommen SR, Nishimura RA, et al Myocardial bridging in adult patients with hypertrophic cardiomyopathy J Am Coll Cardiol 2003;42(5):889–894 205 Yetman AT, McCrindle BW, MacDonald C, Freedom RM, Gow R Myocardial bridging in children with hypertrophic cardiomyopathy–a risk factor for sudden death N Engl J Med 1998;339(17):1201–1209 206 Mohiddin SA, Begley D, Shih J, Fananapazir L Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease J Am Coll Cardiol 2000;36(7):2270–2278 207 Basso C, Thiene G, Mackey-Bojack S, et al Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death Eur Heart J 2009;30(13):1627–1634 208 Kunkala MR, Schaff HV, Burkhart H, et al Outcome of repair of myocardial bridging at the ... 1991;84(3):1188–1197 203 Schantz D, Benson L, Windram J, et al Abnormal mitral valve dimensions in pediatric patients with hypertrophic cardiomyopathy Pediatr Cardiol 2016;37(4):784–788 204 Sorajja P, Ommen SR, Nishimura RA, et al